[HTML][HTML] Degranulation of murine resident cochlear mast cells: A possible factor contributing to cisplatin-induced ototoxicity and neurotoxicity
B Karayay, H Olze, AJ Szczepek - International Journal of Molecular …, 2023 - mdpi.com
Permanent hearing loss is one of cisplatin's adverse effects, affecting 30–60% of cancer
patients treated with that drug. Our research group recently identified resident mast cells in …
patients treated with that drug. Our research group recently identified resident mast cells in …
[PDF][PDF] Degranulation of Murine Resident Cochlear Mast Cells: A Possible Factor Contributing to Cisplatin-Induced Ototoxicity and Neurotoxicity
B Karayay, H Olze, AJ Szczepek - Int. J. Mol. Sci, 2023 - researchgate.net
Permanent hearing loss is one of cisplatin's adverse effects, affecting 30–60% of cancer
patients treated with that drug. Our research group recently identified resident mast cells in …
patients treated with that drug. Our research group recently identified resident mast cells in …
Degranulation of Murine Resident Cochlear Mast Cells: A Possible Factor Contributing to Cisplatin-Induced Ototoxicity and Neurotoxicity
B Karayay, H Olze, AJ Szczepek - International Journal of …, 2023 - search.proquest.com
Permanent hearing loss is one of cisplatin's adverse effects, affecting 30–60% of cancer
patients treated with that drug. Our research group recently identified resident mast cells in …
patients treated with that drug. Our research group recently identified resident mast cells in …
Degranulation of Murine Resident Cochlear Mast Cells: A Possible Factor Contributing to Cisplatin-Induced Ototoxicity and Neurotoxicity.
B Karayay, H Olze, AJ Szczepek - International Journal of Molecular …, 2023 - europepmc.org
Permanent hearing loss is one of cisplatin's adverse effects, affecting 30-60% of cancer
patients treated with that drug. Our research group recently identified resident mast cells in …
patients treated with that drug. Our research group recently identified resident mast cells in …
[HTML][HTML] Degranulation of Murine Resident Cochlear Mast Cells: A Possible Factor Contributing to Cisplatin-Induced Ototoxicity and Neurotoxicity
B Karayay, H Olze, AJ Szczepek - International Journal of …, 2023 - ncbi.nlm.nih.gov
Permanent hearing loss is one of cisplatin's adverse effects, affecting 30–60% of cancer
patients treated with that drug. Our research group recently identified resident mast cells in …
patients treated with that drug. Our research group recently identified resident mast cells in …
Degranulation of Murine Resident Cochlear Mast Cells: A Possible Factor Contributing to Cisplatin-Induced Ototoxicity and Neurotoxicity.
B Karayay, H Olze, AJ Szczepek - International Journal of …, 2023 - search.ebscohost.com
Permanent hearing loss is one of cisplatin's adverse effects, affecting 30–60% of cancer
patients treated with that drug. Our research group recently identified resident mast cells in …
patients treated with that drug. Our research group recently identified resident mast cells in …
Degranulation of Murine Resident Cochlear Mast Cells: A Possible Factor Contributing to Cisplatin-Induced Ototoxicity and Neurotoxicity
B Karayay, H Olze, AJ Szczepek - International journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Permanent hearing loss is one of cisplatin's adverse effects, affecting 30-60% of cancer
patients treated with that drug. Our research group recently identified resident mast cells in …
patients treated with that drug. Our research group recently identified resident mast cells in …
Degranulation of Murine Resident Cochlear Mast Cells: A Possible Factor Contributing to Cisplatin-Induced Ototoxicity and Neurotoxicity
B Karayay, H Olze, AJ Szczepek - Int. J. Mol. Sci, 2023 - europepmc.org
Permanent hearing loss is one of cisplatin's adverse effects, affecting 30–60% of cancer
patients treated with that drug. Our research group recently identified resident mast cells in …
patients treated with that drug. Our research group recently identified resident mast cells in …